Nature GeneticsGenomicsPeer-reviewed journal article
The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides new insights into the genetics of type 1 diabetes
Mireia Ramos-RodrígueziD, Helena Raurell‐VilaiD, Máikel L. ColliiD, Maria Inês AlvelosiD, Marc Subirana-GranésiD, Jonàs Juan‐MateuiD, Richard NorrisiD, Jean‐Valéry TuratsinzeiD, Ernesto Satoshi NakayasuiD, Bobbie‐Jo Webb‐RobertsoniD, Jamie R. J. InshawiD, Piero MarchettiiD, Lorenzo PiemontiiD, Manel EstelleriD, John A. ToddiD, Thomas MetziD, Decio Laks EizirikiD, Lorenzo PasqualiiD
Abstract
Early stages of type 1 diabetes (T1D) are characterized by local autoimmune inflammation and progressive loss of insulin-producing pancreatic {beta} cells. We show here that exposure to pro-inflammatory cytokines unmasks a marked plasticity of the {beta}-cell regulatory landscape. We expand the repertoire of human islet regulatory elements by mapping stimulus-responsive enhancers linked to changes in the {beta}-cell transcriptome, proteome and 3D chromatin structure. Our data indicates that the {beta} cell response to cytokines is mediated by the induction of novel regulatory regions as well as the activation of primed regulatory elements pre-bound by islet-specific transcription factors. We found that T1D-associated loci are enriched of the newly mapped cis-regulatory regions and identify T1D-associated variants disrupting cytokine-responsive enhancer activity in human {beta} cells. Our study illustrates how {beta} cells respond to a pro-inflammatory environment and implicate a role for stimulus-response islet enhancers in T1D.
- organism: human
- assay: bulk RNA-seq
- assay: proteomics
- assay: DNA methylation
- research focus: gene regulatory network inference
- research focus: differential expression
- approach: statistical model
- Citations
- 161
- FWCI
- 11.86
- Field percentile
- top 1%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Type 1 diabetes risk genes mediate pancreatic beta cell survival in response to proinflammatory cytokines
Paola Benaglio, Han Zhu, … Kyle J. Gaulton·Cell GenomicsPeer-reviewed·Nov 11, 2022
- Interferons are the key cytokines acting on pancreatic islets in type 1 diabetes
A. Coomans de Brachene, M. I. Alvelos, … D. L. Eizirik·bioRxiv·Jun 29, 2023
- Genetic risk and inflammatory signaling converge on cell type-specific regulatory programs in type 1 diabetes
- Aberrant TNF signaling in pancreatic lymph nodes of patients with Type 1 Diabetes
Maryam Abedi, Priyadarshini Rai, … Golnaz Vahedi·bioRxiv·May 31, 2024
- Tet2 Controls Beta cells Responses to Inflammation in Type 1 Diabetes
J. Rui, S. Deng, … K. C. Herold·bioRxiv·Sep 1, 2020
- Islet-intrinsic sex differences in inflammatory signaling contribute to autoimmune diabetes susceptibility
Kierstin L. Webster, Armando A. Puente, … Raghavendra G. Mirmira·bioRxiv·Oct 6, 2025